Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations

Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents

(2009) Daniel Scherer et al.   BRITISH JOURNAL OF PHARMACOLOGY

The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study

(2009) Brooke S.G. Molina et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Guide to Receptors and Channels (GRAC), 3rd edition

(2008) S P H Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Microdialysis Evaluation of Atomoxetine Brain Penetration and Central Nervous System Pharmacokinetics in Rats

(2008) W. Kielbasa et al.   DRUG METABOLISM AND DISPOSITION

Neurodevelopmental and neurodegenerative diseases – Is there a pathophysiological link? Attention-deficit/hyperactivity disorder and amyotrophic lateral sclerosis as examples

(2008) D. Lule et al.   MEDICAL HYPOTHESES

N-methyl-d-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder

(2008) V. Jensen et al.   NEUROSCIENCE

Mg2+and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed inXenopus laevisoocytes

(2007) David C. Wrighton et al.   JOURNAL OF PHYSIOLOGY-LONDON